Fig. 2From: Homologous recombination deficiency status predicts response to platinum-based chemotherapy in Chinese patients with high-grade serous ovarian carcinomaHRD score distribution in HRD cohort (n = 118) stratified by BRCA deficiency status (A) and BRCA mutation (B)Back to article page